热门资讯> 正文
Dexcom入选FDA数字医疗服务试点第一家公司
2026-07-23 05:39
- 德康医疗(DXCM) 0
- JPMorgan Climate Change Solutions ETF JPMorgan Climate Change Solutions Fund(TEMP) 0
- 德意志银行(DB) 0
- The US FDA has chosen Dexcom (DXCM) as the first participant in its Technology-Enabled Meaningful Patient Outcomes (TEMPO) Pilot Program.
- The continuous glucose monitor maker said it would "implement an AI-powered glucose health program that integrates data from Dexcom G7 and Stelo with contextual health information such as nutrition, physical activity, sleep and stress, to deliver more personalized insights for healthcare professionals and program eligible users."
- TEMPO's purpose is to examine new digital health technologies that work to improve chronic disease management and provide real-world data.
More on Dexcom
- DexCom: The Growth Thesis Still Needs To Be Proven
- DexCom: A Medical Platform Play Gaining From AI, Not Disrupted By It
- DexCom Might Finally Be Cheap Enough
- DexCom, Insulet gain news Buys at Deutsche Bank despite recent selloff
- DexCom's OTC CGM Stelo gains pediatric approval
推荐文章
华盛早报 | 沃什刚“放鹰”，特朗普转头称加息“荒谬”！智谱上半年API收入飙升27倍；百度双重主要上市今起生效
9月1日外盘头条：俄美财长在G20会议期间罕见会晤 FTC起诉亚马逊 微软Outlook和ChatGPT Work出现用户宕机
美股前瞻 | 苹果换帅！库克明日正式卸任；美伊互袭，油价急涨4%！三大期指齐挫；SK海力士被曝考虑英特尔代工
港股异动 | 半导体股部分走高，壁仞科技涨近8%，上半年营收暴增近2000%；长光辰芯涨逾6.5%
新股申购 | 两只新股今起招股！全球第九大存储器厂商江波龙、中国第三大商用服务机器人供应商优地机器人
华盛早报 | 沃什“放鹰”点燃加息预期！黄金白银遭重挫；房地产政策“组合拳”密集释放；美团Q2调整后净利大超预期；智谱今日放榜
港股周报 | 800亿配售后马云出手“护盘”！阿里周内仍跌7%；百度双重主要上市下周生效；美团、MINIMAX领衔业绩潮
比特币重返技术性牛市！Strategy触底反弹近50%，美股市场还有哪些加密“巨鲸”？
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
